Oncopeptides Innovation AB

ABActive

Org 5593798795Luntmakargatan 46, 111 37 StockholmResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2022 · 4 years old0 employees

Overview Financials People & ownership Related companies

Oncopeptides Innovation AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2022, the company has 0 employees and reported revenue of SEK 4,5M in its latest annual filing.

Revenue 2024

SEK 4,5M

EBITDA margin

100.0%

+448000% vs 2023

Net profit 2024

SEK 0

+100% vs 2023

Key ratios

See full ratios →

0.0%

This company

20222024

0.6×

This company

20222024

0.0%

This company

20222024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 4,5M	—
EBITDA	SEK 4,5M	+448000%
Net profit	SEK 0	+100%
Total assets	SEK 534,3M	+7511%
Equity	SEK 19K	0%
Employees	0	—

Contact

Address

Luntmakargatan 46, 111 37 Stockholm

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Oncopeptides Innovation AB?

Oncopeptides Innovation AB is registered with Bolagsverket / SCB under Org 5593798795.

What is the revenue of Oncopeptides Innovation AB?

Oncopeptides Innovation AB reported revenue of SEK 4,5M in 2024.

Who is the chairman of Oncopeptides Innovation AB?

Eric Henrik Bergentoft chairs the board of Oncopeptides Innovation AB.

Where is Oncopeptides Innovation AB headquartered?

Oncopeptides Innovation AB's registered address is Luntmakargatan 46.

Oncopeptides Innovation AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Oncopeptides Innovation AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Oncopeptides Innovation AB